PIK3R1 and overgrowth syndrome: Furthermore, studies to elucidate the molecular mechanisms underlying pathogenic variation of PIK3R1 with widely disparate clinical phenotypes, including both under- and overgrowth syndromes and immunoregulation, will unify our understanding of this critical cellular proliferation pathway and provide further insight into treatment.